Kate Smolina
Kate Smolina
Director, BC Observatory for Population & Public Health
Verified email at bccdc.ca - Homepage
Title
Cited by
Cited by
Year
Coronary heart disease statistics 2012
N Townsend, K Wickramasinghe, P Bhatnagar, K Smolina, M Nichols, ...
British Heart Foundation, 2012
4152012
Coronary heart disease statistics 2012
N Townsend, K Wickramasinghe, P Bhatnagar, K Smolina, M Nichols, ...
British Heart Foundation, 2012
4152012
Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study
K Smolina, FL Wright, M Rayner, MJ Goldacre
Bmj 344, 2012
4052012
Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010
K Smolina, FL Wright, M Rayner, MJ Goldacre
Circulation: Cardiovascular Quality and Outcomes 5 (4), 532-540, 2012
2432012
Coronary heart disease statistics 2010 edition
P Scarborough, P Bhatnagar, K Wickramasinghe, K Smolina, C Mitchell, ...
British Health Foundation Health Promotion research group, Department of …, 2010
2232010
The Canadian Rx Atlas
S Morgan, K Smolina, D Mooney, C Raymond, ML Bowen, C Gorczynski, ...
Centre for Health Services and Policy Research (CHSPR), 2013
1122013
Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults
SG Morgan, D Weymann, B Pratt, K Smolina, EJ Gladstone, C Raymond, ...
Age and ageing 45 (4), 535-542, 2016
622016
Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998–2011: a retrospective national record linkage cohort study
K Smolina, CJ Wotton, MJ Goldacre
Diabetologia 58 (5), 942-950, 2015
622015
Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002–2011: a population-based cohort study
K Smolina, GE Hanley, B Mintzes, TF Oberlander, S Morgan
PloS one 10 (5), e0128312, 2015
612015
Postmarket policy considerations for biosimilar oncology drugs
MJ Renwick, K Smolina, EJ Gladstone, D Weymann, SG Morgan
The Lancet Oncology 17 (1), e31-e38, 2016
542016
Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study
K Smolina, FL Wright, M Rayner, MJ Goldacre
The European Journal of Public Health 22 (6), 848-853, 2012
532012
Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: problem for young women
K Smolina, L Ball, KH Humphries, N Khan, SG Morgan
Circulation: Cardiovascular Quality and Outcomes 8 (6), 586-592, 2015
432015
Postpartum hemorrhage and use of serotonin reuptake inhibitor antidepressants in pregnancy
GE Hanley, K Smolina, B Mintzes, TF Oberlander, SG Morgan
Obstetrics & Gynecology 127 (3), 553-561, 2016
412016
Ethnic differences in cardiovascular disease
P Scarborough, P Bhatnagar, A Kaur, K Smolina, K Wickramasinghe, ...
London: Department of Public Health, University of Oxford, 2010
412010
The association between domperidone and ventricular arrhythmia in the postpartum period
K Smolina, B Mintzes, GE Hanley, TF Oberlander, SG Morgan
Pharmacoepidemiology and drug safety 25 (10), 1210-1214, 2016
282016
Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015–2016
K Smolina, A Crabtree, M Chong, B Zhao, M Park, C Mill, CG Schütz
Drug and alcohol dependence 194, 151-158, 2019
272019
Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada
EJ Gladstone, K Smolina, D Weymann, K Rutherford, SG Morgan
Medical care 53 (11), 954-959, 2015
262015
Trends and sex differences in prescription opioid deaths in British Columbia, Canada
EJ Gladstone, K Smolina, SG Morgan
Injury prevention 22 (4), 288-290, 2016
252016
Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020
DM Skowronski, I Sekirov, S Sabaiduc, M Zou, M Morshed, D Lawrence, ...
medRxiv, 2020
242020
Determinants of trends in prescription opioid use in British Columbia, Canada, 2005–2013
K Smolina, E Gladstone, SG Morgan
Pharmacoepidemiology and drug safety 25 (5), 553-559, 2016
232016
The system can't perform the operation now. Try again later.
Articles 1–20